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Abstract 
Background: Prehospital care for patients with traumatic brain injury (TBI) varies with some emergency medical sys-
tems recommending direct transport of patients with moderate to severe TBI to hospitals with specialist neurotrauma 
care (SNCs). The aim of this study is to assess variation in levels of early secondary referral within European SNCs and 
to compare the outcomes of directly admitted and secondarily transferred patients.
Methods: Patients with moderate and severe TBI (Glasgow Coma Scale < 13) from the prospective European CENTER-
TBI study were included in this study. All participating hospitals were specialist neuroscience centers. First, adjusted 
between-country differences were analysed using random effects logistic regression where early secondary referral 
was the dependent variable, and a random intercept for country was included. Second, the adjusted effect of early 
secondary referral on survival to hospital discharge and functional outcome [6 months Glasgow Outcome Scale 
Extended (GOSE)] was estimated using logistic and ordinal mixed effects models, respectively.
Results: A total of 1347 moderate/severe TBI patients from 53 SNCs in 18 European countries were included. Of these 
1347 patients, 195 (14.5%) were admitted after early secondary referral. Secondarily referred moderate/severe TBI 
patients presented more often with a CT abnormality: mass lesion (52% vs. 34%), midline shift (54% vs. 36%) and acute 
subdural hematoma (77% vs. 65%). After adjusting for case-mix, there was a large European variation in early second-
ary referral, with a median OR of 1.69 between countries. Early secondary referral was not associated with functional 
outcome (adjusted OR 1.07, 95% CI 0.78–1.69), nor with survival at discharge (1.05, 0.58–1.90).
Conclusions: Across Europe, substantial practice variation exists in the proportion of secondarily referred TBI patients 
at SNCs that is not explained by case mix. Within SNCs early secondary referral does not seem to impact functional 
outcome and survival after stabilisation in a non-specialised hospital. Future research should identify which patients 
with TBI truly benefit from direct transportation.
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Background
Traumatic brain injury (TBI) remains an important cause 
of injury-related death and disability [1]. The incidence of 
TBI is increasing as the patient population becomes older 
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[2, 3]. Care in specialized neurotrauma centers (SNC) 
with neurosurgical and neurocritical care expertise can 
reduce the incidence of death and disability from head 
injury, especially in more severe TBI [4–6]. However, not 
all TBI patients are directly transported to a SNC if this is 
not the nearest facility. In the prehospital setting Emer-
gency Medical Services (EMS) should decide whether 
these patients should be stabilized at the nearby non 
specialist acute hospital (NSAH) or directly transported 
to a more distant SNC. After stabilization and com-
puted tomography (CT) scan at a NSAH—the decision is 
made regarding the need for specialist neurotrauma care 
(including neurosurgery and neurointensive cares [7]) 
via secondary transfer. Stabilizing the patient at a nearby 
NSAH may cause an important time delay to critical neu-
rosurgical and neurocritical care interventions which 
could adversely affect the outcome of TBI patients [8]. 
On the other hand prolonged primary transportation to 
a more distant specialist center could delay direct access 
to critical interventions such as drug assisted intubation, 
which prevents hypoxia and hypotension, that can induce 
secondary brain injury [9]. This is pertinent particu-
larly to the majority of EMS staff who do not have this 
advanced airway skill [10]. Early neurosurgery might be 
a lower priority than early treatment of secondary insults 
such as hypoxia and hypotension [11]—the latter being 
addressed by hospital based damage control measures 
and balanced transfusion. The decision which patients 
should be conveyed directly to an SNC is made on-scene 
by EMS staff based on clinical parameters, injury charac-
teristics and the local policy through trauma triage tools 
[10]. A systematic review on this issue failed to identify 
clear benefit from direct transportation to SNCs [11]. A 
recent randomized trial also failed to identify benefit as 
the majority of patients who bypass the NSAH are sub-
sequently shown not to have a brain injury on CT scan, 
diluting the impact of early access to neurotrauma care 
[12, 13].
Notwithstanding this equivocal evidence base, several 
international guidelines recommend direct transporta-
tion of patients with moderate/severe TBI to hospitals 
with availability of neurosurgical care in order to reduce 
the time delay [14–16]. There might be substantial varia-
tion in referral practice between regions and countries. It 
remains unclear how long term outcomes of secondarily 
referred patients relate to outcomes of patients directly 
transported to a SNC, also in terms of secondary brain 
damage associated with hypoxia and hypotension.
Therefore, the aims of this study are, (1) to quantify 
European practice variation in early secondary referrals, 
and (2) to determine the association of arriving by early 
secondary referral with hypoxia and/or hypotension, sur-
vival at discharge and functional outcome at 6 months.
Methods
Study design
The Collaborative European NeuroTrauma Effectiveness 
Research in TBI (CENTER-TBI) study is a multicenter, 
longitudinal, prospective, observational study in 22 coun-
tries across Europe and Israel which enrolled patients 
between December 2014 and December 2017 [17]. All 
study sites are specialist neurotrauma centers [17]. The 
core cohort includes patients presenting within 24  h of 
injury, with a clinical diagnosis of TBI and indication for 
CT. Data for the CENTER-TBI study has been collected 
through the Quesgen e-CRF (Quesgen Systems Inc, 
USA), hosted on the INCF platform and extracted via the 
INCF Neurobot tool (INCF, Sweden).
We validated the generalizability of our analysis in the 
Center-TBI registry, comprising of all patients present-
ing at one of the study centers between December 2014 
and December 2017 with a clinical diagnosis of TBI and 
indication for CT scan [17]. For the registry, informed 
consent was not necessary and collected purely adminis-
trative data which resulted in more included patients.
Version 2.1 of the core and registry Neurobot data sets 
were used for this study. Prehospital data was collected 
by physicians at the study centers. Policy and center spe-
cific data was collected by provider profiling question-
naires, filled in by the leading researchers of each study 
center [18]. Relevant questions from the provider profil-
ing questionnaires to explain regional differences were 
the existence of a prehospital triage tool concerning 
direct transportation to more distant specialist neuro-
trauma centres and level of education of the prehospital 
staff.
Ethical approval was obtained for each recruiting site. 
Consent was obtained for all patients enrolled in the 
Core study. The list of sites, Ethical Committees, approval 
numbers and approval dates can be found on the website: 
https:// www. center- tbi. eu/ proje ct/ ethic al- appro val.
Patient selection
We included all patients with moderate/severe TBI 
when presenting to the study center (defined as a Glas-
gow Coma Scale (GCS) < 13 or intubated [19]) who were 
transported by ambulance or helicopter directly to a 
study center (SNC) or admitted after early secondary 
referral within 24 h. Both patients with isolated TBI and 
polytrauma patients were included. A sensitivity analysis 
was done by including all CENTER-TBI registry patients 
with moderate/severe TBI. This study was reported in 
accordance with the STROBE reporting guidelines [20].
Definitions
The outcome measures to estimate the effect of 
early secondary referral were hypoxia at ED arrival 
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(saturation < 90%), hypotension at ED arrival (systolic 
blood pressure < 90  mmHg), survival at discharge and 
6 months Glasgow Outcome Scale Extended (GOSE). For 
cases in which GOSE assessments had been performed 
outside the pre-specified window of 5–8 months, a multi-
state model was made by the CENTER-TBI statisticians 
to impute the 180-day GOSE [1, 21]. This imputed GOSE 
variable was made by the CENTER-TBI statisticians and 
was directly extracted from the CENTER-TBI Neurobot 
dataset [22]. This enables all CENTER-TBI research-
ers to use the same outcome variable. All other variables 
extracted from the CENTER-TBI Neurobot dataset were 
not imputed at the start of this research project. The 
following potential confounders between the relation-
ship of transfer status and outcome were extracted from 
the CENTER-TBI Neurobot dataset because they were 
assumed to be associated with either arriving by early 
secondary referral or part of the International Mission 
for Prognosis and Analysis of Clinical Trials (IMPACT) 
model: age, GCS motor score at first Emergency Depart-
ment (ED) arrival, pupil inequality at first ED arrival, 
hypoxia at ED arrival, hypotension at ED arrival, Injury 
Severity Score (ISS) and several CT abnormalities: trau-
matic subarachnoid haemorrhage (tSAH), epidural 
hematoma, mass lesion and acute subdural hematoma 
[23].
Outcomes
Our primary outcome in order to quantify European 
practice variation is referral status (primary versus early 
secondary referral). Our secondary outcomes to deter-
mine the association between referral status and out-
comes are 6 months GOSE, survival at discharge, hypoxia 
and hypotension. For the analysis in the CENTER-TBI 
registry, we used survival at discharge as outcome meas-
ure since longer term outcome data were not collected in 
the Registry.
Statistical analysis
Continuous variables were described by the median 
and interquartile range (IQR). Categorical variables 
were described by the frequency and percentage. 
Missing data was imputed using multiple imputation, 
assuming missing at random (MAR). Missingness at 
random was assumed because the missingness present 
in our study can be accounted for by variables where 
there is complete information [24]. Missing data were 
multiply imputed for the main analyses using the ‘mice’ 
package. Together with the potential confounders men-
tioned above, referral status was included in the impu-
tation model. Five imputed datasets were obtained. All 
variables, except for the outcome variables survival 
at discharge and the derived 6  months GOSE, were 
imputed. However, the outcome variables were 
included in the imputation model.
First, adjusted between-country differences were 
analyzed by adding a random intercept for country to 
a logistic regression model with early secondary refer-
ral as dependent variable. National variation or practice 
variation was quantified using the Median Odds Ratio 
[MOR, median odds ratio (OR) between two randomly 
picked countries/centers] [25].
Second, the effect of arriving by early secondary 
referral on hypotension and hypoxia was estimated 
using random effects logistic regression models. We 
adjusted for age, GCS motor score, pupil inequality, ISS 
and a random intercept for study center.
Third, the effect of arriving by early secondary refer-
ral on survival at discharge and functional outcome 
(6 months GOSE) was estimated using random effects 
regression models. For in-hospital mortality, a ran-
dom effects logistic regression model was used, which 
included the predefined confounders and a random 
intercept for study center. For 6 months GOSE, a ran-
dom effects ordinal regression model was used with 
similar structure. A subgroup analysis was done by 
including patients who presented with either a mass 
lesion or acute subdural hematoma on CT scan. This 
subgroup analysis used the same confounders to adjust 
for expect for CT abnormalities since this was the 
inclusion criterion of the subgroup analysis.
As a secondary sensitivity analysis in order to validate 
our results and assess generalizability, the same analysis 
was repeated in the CENTER-TBI registry with more 
heterogenous patients with survival at discharge as 
outcome measure. A random effects logistic regression 
model with the same case-mix variables was used with 
a random intercept for study center. Finally, as sensitiv-
ity analysis, the main analyses were also repeated in the 
complete cases only.
Continuous variables within the models were 
checked graphically for nonlinearity and were han-
dled using restricted cubic splines when nonlinearity 
was assumed. Variables within models were checked 
for potential multicollinearity using correlation matri-
ces. We did not check interactions terms because there 
were not enough degrees of freedom to do this.
Statistical analyses were performed in R statistical 
software 3.5.1 (R Foundation for Statistical Computa-
tion, Vienna). The glmer function from the lme4 pack-
age was used for mixed effects logistic regression, the 
clmm function from the ordinal package was used for 
ordinal mixed effects logistic regression, and multiple 
imputation was performed using the MICE package.
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Results
Patient characteristics
A total of 1347 patients with moderate/severe TBI were 
included in this study from 53 study centers in 18 Euro-
pean countries. Of these 1347 patients, 195 (14.5%) 
were transferred from another hospital. The propor-
tion of TBI patients arriving through early second-
ary referrals varied by study center from 0 to 71%. The 
patients secondarily referred to the study center were 
mostly male (146, 74.9%), with a median age of 52 years 
(IQR 29–67), a median GCS of 7 (IQR 3–10), were not 
often intubated compared to primary referred in the 
prehospital environment (37, 20.7%) and their median 
ISS was 26 (25–41). The patients who were primar-
ily transported to study centres were also mostly male 
(837, 72.7%), young to middle aged (median age was 47, 
IQR 28–65), with a GCS of 7 (4–10), however they were 
often intubated on-scene (701, 62.1%);their median ISS 
was 34 (25–45) (Table  1, Additional file  2: Figure S1). 
Mode of injury differed between both patient groups 
where road traffic incidents with extracranial injury 
were more common in TBI patients arriving by primary 
referral. When looking at the prehospital characteris-
tics, patients secondarily referred had fewer on scene 
interventions (e.g. intubation, IV fluids) compared to 
primarily transported patients (Table 1).
Patients arriving after early secondary referral had 
more serious abnormalities on CT imaging; 131 (77.1%) 
of patients arriving by secondary transfer had an acute 
subdural hematoma, compared to 700 (64.6%) of the 
directly admitted patients; 79 (52.0%) of the referred 
patients had a mass lesion, compared to 347 (34.1%) of 
those arriving directly from the scene. The average time 
from injury to emergency surgery was approximately 
210  min for directly admitted patients compared to 
345 min when arriving by early secondary referral.
The median 6 months GOSE was 4 (IQR 1–6) among 
primary referred patients and 4 (IQR 1–7) among early 
secondary referred patients. In-hospital mortality was 
21.2% among primary referred patients and 19.4% 
among secondarily referred patients.
European practice variation of early secondary referrals
When analysing European practice variation, patients 
admitted to specialist neurotrauma centers in Scan-
dinavian countries, Austria and England were more 
often secondarily referred (Fig. 1). Patients in the Neth-
erlands and Italy had relatively lower adjusted chance 
of arriving by early secondary referral. The MOR is 
1.69 which means that the OR between two randomly 
picked countries is 1.69 for the average TBI patient 
included in our study.
Effect of early secondary referral on outcome
There was no association between type of referral and 
hypotension and hypoxia at arrival at the SNC (unad-
justed OR 0.53 with direct admission as reference, 95% CI 
0.27–1.02 for hypoxia and OR 0.65 with direct admission 
as reference, 95% CI 0.36–1.19 for hypotension, Table 2). 
After adjustment, there were similar results (OR 0.57 
with direct admission as reference, 95% CI 0.28–1.15 for 
hypoxia and OR 0.72 with direct admission as reference, 
95% CI 0.38–1.38 for hypotension). Arriving by early sec-
ondary referral as moderate/severe TBI patient was not 
associated with 6 month GOSE (unadjusted OR 1.13 with 
direct admission as reference, 95% CI 0.82–1.55). After 
adjusting for confounders, arriving by early secondary 
referral as moderate/severe TBI patient was not associ-
ated with 6 month GOSE (multivariable adjustment, OR 
1.07 with direct admission as reference, 95% CI 0.78–
1.46, Table 3) and there was no association between early 
secondary referral and survival at discharge (OR 1.05 
with direct admission as reference, 95% CI 0.58–1.90). 
Subgroup analysis of patients with a mass lesion or acute 
subdural hematoma and patients needing emergency 
intracranial surgical intervention showed similar mag-
nitude and direction of the effects (Table  3). Complete 
case analysis showed similar results (Additional file  1: 
Table S3, Table S4).
Sensitivity analysis in the registry
A total of 2150 moderate/severe TBI patients were 
included in the registry of which 25% arrived by sec-
ondary transfer, the characteristics of both groups were 
similar to patients in the core study (Additional file  1: 
Table  S1). Secondarily referred patients had craniotomy 
for hematoma more often as emergency intervention 
[171 (10.5%) of directly admitted and 164 (31.4%) of sec-
ondarily referred patients]. Also, the CT scans of second-
arily referred patients more frequently showed midline 
shift (54.5% for secondarily referred vs. 37.5% for directly 
admitted). There was no association between arriving by 
early secondary referral and survival at discharge after 
adjustment for confounders (OR 1.21 95% CI 0.84–1.73, 
Additional file 1: Table S2).
Discussion
This study showed that variation in the proportion of 
moderate and severe TBI patients who have been second-
arily referred to European specialist centres varied sig-
nificantly by country after adjusting for case-mix factors. 
The secondarily referred TBI patients received less pre-
hospital interventions. However, they had more serious 
abnormalities at CT scanning. Secondarily referred TBI 
patients were not associated with fewer secondary insults 
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Table 1 Patient characteristics, continuous: median (IQR), categorical: number (%); including percentage missingness for patient 
characteristics from core dataset (N = 1347)
Primary referral
(N = 1152)
% missing Early secondary referral
(N = 195)
% missing p value
Patient characteristics
Male (%) 837 (72.7) 0.0 146 (74.9) 0.0 0.52
Age (median [IQR]) 47 [28, 65] 0.0 52 [29, 67] 0.0 0.34
Alcohol usage (%) 295 (29.0) 11.6 71 (42.3) 13.8 0.001
Drugs usage (%) 50 (5.4) 20.3 10 (7.4) 30.3 0.37
Injury characteristics
Cause of injury (%) 10.9 15.9 < 0.001
 Fall 420 (40.9) 84 (51.2)
 Road traffic incident 551 (53.7) 60 (36.6)
 Suicide 26 (2.5) 3 (1.8)
 Violence 30 (2.9) 17 (10.4)
Area of injury = urban (%) 837 (75.0) 3.1 143 (76.5) 4.1 0.67
Place of injury (%) 2.3 5.1 < 0.001
 Home 275 (24.4) 50 (27.0)
 Public location 66 (5.9) 35 (18.9)
 Sport 56 (5.0) 7 (3.8)
 Street 663 (58.9) 86 (46.5)
 Work 66 (5.9) 7 (3.8)
GCS at arrival ED (median [IQR]) 6 [3, 9] 0.0 7 [3, 10] 0.0 < 0.001
Hypoxia at arrival ED 186 (16.9) 0.0 18 (10.3) 0.0 < 0.001
Hypotension at arrival ED 196 (17.9) 0.0 20 (11.7) 0.0 < 0.001
Total ISS (median [IQR]) 34 [25, 45] 0.7 26 [25, 41] 1.0 0.03
Major extracranial injury (AIS > 3) (%) 652 (57.0) 0.7 83 (43.0) 1.0 < 0.001
Pupil differences at ED (%) 3.4 6.7 0.10
 No pupil difference 809 (72.7) 146 (80.2)
 One pupil not reactive 94 (8.4) 12 (6.6)
 Two pupils not reactive 210 (18.9) 24 (13.2)
Prehospital care
Intubation (%) 701 (62.1) 2.1 37 (20.7) 8.2 < 0.001
Ventilation (%) 646 (58.0) 3.4 35 (19.7) 8.7 < 0.001
CPR (%) 35 (3.0) 0.0 2 (1.0) 0.0 0.11
Oxygen supply (%) 853 (78.8) 6.1 97 (65.5) 24.1 < 0.001
IV fluids (%) 727 (63.1) 0.0 65 (33.3) 0.0 < 0.001
Physician on scene (%) 858 (74.7) 0.3 86 (44.6) 1.0 < 0.001
Mode of transport (%) 0.0 0.0 < 0.001
 Ambulance 769 (66.8) 160 (82.1)
 Helicopter 271 (23.5) 16 (8.2)
 Medical mobile team 112 (9.7) 19 (9.7)
Time from leaving scene to first hospital (median [IQR]) 20 [12, 39] 41.8 11 [9, 24] 88 0.02
Time to study center (median [IQR]) 20 [12, 39] 41.8 205[160, 286] 53 < 0.001
Local policy characteristics
Prehospital triage protocol favours direct admission (%) 334 (46.7) 37.9 28 (27.2) 47.2 < 0.001
Training of prehospital staff (%) 19.4 24.1 0.61
 BLS only 168 (18.1) 22 (14.9)
 Emergency medical technician 590 (63.6) 99 (66.9)
 Nurse 170 (18.3) 27 (18.2)
Imaging characteristics
Acute subdural hematoma (%) 700 (64.6) 5.9 131 (77.1) 12.8 0.004
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(hypoxia and hypotension at ED arrival). We found no 
association between early secondary referral and clinical 
long term outcomes. These findings were confirmed in 
the registry database, including a larger and more heter-
ogenous population.
The European variation in the proportion of early sec-
ondary referrals to specialist centres is large, and only 
partly confirmed in previous literature. The likelihood 
of arriving by early secondary referral was lowest in the 
Netherlands and Italy. A previous Italian study showed 
that 58% of the TBI patients presenting at SNCs in the 
whole country were referred from another peripheral 
hospital [26]. However, Italian centers that contrib-
uted to CENTER-TBI were mainly situated in North-
ern Italy. Fifteen years ago, an English study found 
that one third of the severe head injury patients were 
treated in non-neurotrauma centers which was associ-
ated with higher mortality [27]. A study from Greece 
found that around half of the TBI patients in specialist 
centres were secondarily referred, higher than our find-
ings. Early secondary referral increased the travel time 
to a neurosurgical center by 3.5  h [28]. The percent-
age of early secondary referrals seems to be decreasing 
when comparing our sample of moderate/severe TBI 
patients to older European studies. The percentage of 
secondarily referred patients was highest in Scandina-
vian countries, Austria and the UK. This is in line with 
their geography, less densely populated areas with long 




% missing Early secondary referral
(N = 195)
% missing p value
Traumatic subarachnoid hemorrhage (%) 747 (73.6) 11.9 114 (76.5) 23.6 0.449
Epidural hematoma (%) 165 (16.2) 11.7 28 (18.7) 23.1 0.452
Skull fracture (%) 617 (59.9) 10.6 104 (65.8) 19.0 0.115
Midline shift (%) 377 (35.6) 8.0 91 (53.8) 13.3 0.007
Cisternal compression (%) 435 (41.6) 9.3 81 (50.6) 17.9 0.142
Mass lesion (%) 347 (34.1) 11.6 79 (52.0) 22.1 < 0.001
Intraventricular hemorrhage (%) 290 (28.6) 12.0 41 (27.0) 22.1 0.678
Contusion (%) 734 (69.3) 8.1 134 (79.3) 13.3 0.033
Emergency intracranial surgical intervention (%) 286 (24.9) 0.3 62 (32.1) 1.0 0.034
Time from injury to emergency surgery (median [IQR]) 210 [150, 348] 37 345 [259, 479] 20.6 < 0.001
Outcome
6 Months GOSE (median [IQR]) 4.00 [1.00, 6.00] 12.7 4.00 [1.00, 7.00] 14 0.430
Unfavourable outcome (GOSE < 5, %) 491 (48.8) 12.7 62 (37.3) 14 < 0.001
In-hospital mortality (%) 190 (20.0) 17.7 30 (18.5) 16.9 0.610
Fig. 1 European practice variation in early secondary referrals, 
adjusted for extended IMPACT model (age, GCS motor score, pupil 
inequality, hypoxia, hypotension, ISS, CT lesions: tSAH, epidural 
hematoma, mass lesion, acute subdural hematoma). Log Odds 
represents the chance of arriving by early secondary referral for the 
mean moderate/severe TBI patient compared to the mean European 
chance of being referred. A log-odds above 0 means more chance 
than average of arriving by early secondary referral, a log odds below 
0 means less chance than average of arriving by early secondary 
referral
Table 2 Effect of early secondary referral on hypotension 
and hypoxia at arrival at the Emergency Department of the 
Specialized Neurotrauma Center
There were 186 primary referred patients with hypoxia and 18 secondary 
referred patients with hypoxia. There were 196 primary referred patients with 
hypotension and 20 primary referred patients with hypotension
a Adjusted for: age, GCS motor score, pupil inequality, ISS and a random 
intercept for center
Hypoxia OR (95% CI) Hypotension OR (95% CI)
Unadjusted 0.53 (0.27–1.02) 0.65 (0.36–1.19)
Multivariable 
 adjustmenta
0.57 (0.28–1.15) 0.72 (0.38–1.38)
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patients at closer non-specialised acute hospitals in 
order to avoid secondary insults.
Earlier research suggested that arriving by early sec-
ondary referral is associated with worse outcomes in 
severe TBI patients [8, 27, 29, 30]. One of the most 
important explanations for worse outcomes being the 
time delay which could result in secondary brain damage 
due to hypotension and hypoxia [31]. Also, care in cen-
tres that practice high-volume protocol-driven therapy, 
like ICP monitoring, is associated with better outcomes 
especially when neurocritical interventions are necessary 
[32, 33]. However, we could not find an effect of early 
secondary referral on long term outcomes. A meta-anal-
ysis including eleven studies found comparable results 
[12]. This is in line with previous research, suggesting 
that time interval to surgery was not associated with 
outcomes in patients with acute subdural hematomas 
requiring surgery [34]. Since subdural hematomas were 
the most prevalent CT abnormality in early secondary 
referred patients, these data suggest that these patients 
can safely be stabilised in non-specialised centers.
Our study shows that the impact of time to emergency 
surgery on outcomes becomes less critical when sec-
ondary insults (hypoxia and hypotension) are avoided. 
Hypoxia and hypotension are although less frequently 
observed over time in TBI patients still strongly associ-
ated with worse long term outcomes [35, 36]. We found 
no differences in secondarily referred TBI patients arriv-
ing with hypoxia or hypotension compared to directly 
admitted TBI patients at the Specialised Neurotrauma 
Centre. This is not in line with previous research which 
shows that interventions to treat life-threatening events 
may significantly decrease mortality [37]. We do see a 
non-significant association between arriving by second-
ary referral and less hypoxia or hypotension. We believe 
that shortened on-scene time and prompt transport to a 
non-specialist acute care facility where patients can be 
stabilized is associated with less hypoxia and hypoten-
sion when arriving at the specialized neurotrauma center. 
This is also in line with the trial of Bernard which shows 
that prompt intubation is associated with improved func-
tional outcome in severe TBI patients [9]. When intuba-
tion is not possible in the prehospital field, it is important 
to transport the patient to the nearest acute care facility 
as soon as possible [35]. The reason for not finding a sig-
nificant association might be the study power needed to 
show this association.
This study has several strengths. CENTER-TBI is 
a multicenter study in 22 European countries, which 
increases external validity. External validity is further 
increased because we were able to validate our findings 
for the effect of early secondary referral on outcome in 
the CENTER registry. We could rigorously adjust for 
potential case-mix differences due to the broad data col-
lection of CENTER-TBI, and assess both survival and 
long term functional outcome.
However, our study also has several limitations. The 
biggest limitation of our study is the fact that we miss 
information about patients who died at the first hospi-
tal. This could introduce a selection bias where patients 
secondary referred to SNCs are the survivors of the 
first hospital they were admitted to. First, we could only 
include patients that were referred to a neurosurgical 
study center within 24  h after injury. Some moderate/
severe TBI patients who may have benefited from spe-
cialised care might not have been transferred, or might 
Table 3 Effect of early secondary referral on GOSE and survival at discharge
Higher OR for 6 months GOSE means better outcome, while higher OR for survival at discharge means higher chance of survival
a Adjusted for: age, GCS motor score, pupil inequality, hypoxia, hypotension, ISS, CT lesions: tSAH, epidural hematoma, mass lesion, acute subdural hematoma, and a 
random intercept for center






Unadjusted 1.13 (0.82–1.55) 1.04 (0.65–1.62)
Multivariable  adjustmenta 1.07 (0.78–1.46) 1.05 (0.58–1.90)
Subgroup: patients with mass lesion/ASDH N = 691 N = 651
Unadjusted 1.64 (1.10–2.44) 1.24 (0.67–2.32)
Multivariable  adjustmentb 1.28 (0.86–1.93) 1.02 (0.64–1.64)
Subgroup: patients with emergency intracranial surgical intervention N = 301 N = 293
Unadjusted 1.51 (0.85–2.69) 1.59 (0.68–3.72)
Multivariable  adjustmentb 1.56 (0.89–2.74) 1.61 (0.56–4.76)
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have been transferred after 24 h. Late secondary transfers 
are associated with worse outcomes [38]. Second, inevi-
tably our large multicentre prospective observational 
study meant data was missing for some variables and 
confounding bias could not be excluded. For example, 
time to first hospital was missing in 50% of the cases. This 
was addressed by using multiple imputation, a method 
proven to give valid estimates under the missing at ran-
dom assumption [39]. We used random effects multi-
variable models to adjust for potential confounders and 
further adjust for potential between-center differences 
in study population. However, we cannot exclude resid-
ual confounding bias. Also, we adjusted for many factor 
which could also introduce over-adjustment. Potential 
confounding factors were selected on clinical reasoning 
and the IMPACT model. Third, the between-country and 
between-center differences could not be explained by 
the captured policy and care characteristics [18]. Fourth, 
since CENTER-TBI is a large multicentre prospective 
cohort study measurement errors were inevitable. We 
dealt with this by checking the dataset on impossible 
values (for example a heart rate of 999), and these values 
were checked in the patient records. When no mistake 
could be found, values were made missing. Fifth, regres-
sion dilution bias due to measurement error or random 
noise is possible. Last, geographical differences like the 
distance from scene to the specialised center, or the num-
ber of specialised neurosurgical centers per  km2 were not 
measured at a patient level.
The debate about whether or not to transport TBI 
patients directly to specialist neurotrauma centers—past 
closer non specialist hospitals—has not yet been con-
cluded. We were not able to find an association between 
early secondary referral and outcome. Intuitively, arriv-
ing by early secondary referral with extended time from 
injury to definitive treatment remains undesirable. One 
could look for alternatives. An English study shows for 
example that observation in a non-specialised hospital 
with neurosurgical consult by e-health and repeated CT 
scanning was not associated with worse outcomes for 
TBI patients [40]. However, this could lead to extra trans-
fers between hospitals and increasing health care costs.
Once moderate/severe TBI patients are stabilised (on-
scene or at the first hospital), it is possible that there is 
no effect of the time delay on outcome anymore. Patients 
arriving by early secondary referral receive less inter-
ventions on-scene, but do have more serious CT brain 
scan abnormalities, highlighting the limitations of cur-
rent prehospital triage tools. Future research in this area 
also needs to include patients with TBI admitted to non-
specialist hospitals. This will enable assessment of sub-
groups of TBI patients with benefit from direct transport 
to SNCs. Consequently, this would also allow further 
evaluation of the cost-effectiveness of direct transport to 
SNCs which was recently shown to be equivocal [41].
Conclusions
Across Europe, substantial practice variation exists in 
the proportion of secondarily referred moderate/severe 
TBI patients within specialised neurotrauma centers. 
Patients who are secondarily referred present less often 
with secondary insults, although they have more serious 
CT abnormalities. Future research should focus upon 
which on scene characteristics identify TBI patients that 
benefit from direct transportation to distant specialist 
neurotrauma centers in order to improve guidelines and 
outcomes for patients with TBI.
Abbreviations
CI: Confidence interval; CT: Computed tomography; EMS: Emergency medical 
services; GCS: Glasgow Coma Score; GOSE: Glasgow Outcome Scale Extended; 
IQR: Interquartile range; NSAH: Non specialized acute hospital; OR: Odds ratio; 
SNC: Specialized neurotrauma center; TBI: Traumatic brain injury.
Supplementary Information
The online version contains supplementary material available at https:// doi. 
org/ 10. 1186/ s13049- 021- 00930-1.
Additional file 1. Table S1 and S2.
Additional file 2. Figure S1.
Acknowledgements
The CENTER-TBI participants and investigators: Cecilia Åkerlund1, Krisztina 
 Amrein2, Nada  Andelic3, Lasse  Andreassen4, Audny  Anke5, Anna  Antoni6, 
Gérard  Audibert7, Philippe  Azouvi8, Maria Luisa  Azzolini9, Ronald  Bartels10, Pál 
Barzó11, Romuald  Beauvais12, Ronny  Beer13, Bo-Michael  Bellander14, Antonio 
 Belli15, Habib  Benali16, Maurizio  Berardino17, Luigi  Beretta9, Morten  Blaabjerg18, 
Peter  Bragge19, Alexandra  Brazinova20, Vibeke  Brinck21, Joanne  Brooker22, 
Camilla  Brorsson23, Andras  Buki24, Monika  Bullinger25, Manuel  Cabeleira26, 
Alessio  Caccioppola27, Emiliana  Calappi27, Maria Rosa  Calvi9, Peter  Cameron28, 
Guillermo Carbayo  Lozano29, Marco  Carbonara27, Giorgio  Chevallard30, Arturo 
 Chieregato30, Giuseppe  Citerio31, 32, Maryse  Cnossen33, Mark  Coburn34, 
Jonathan  Coles35, D. Jamie  Cooper36, Marta  Correia37, Amra Čović 38, Nicola 
 Curry39, Endre  Czeiter24, Marek  Czosnyka26, Claire Dahyot-Fizelier40, Helen 
 Dawes41, Véronique De  Keyser42, Vincent  Degos16, Francesco Della  Corte43, 
Hugo den  Boogert10, Bart  Depreitere44, Đula Đilvesi 45, Abhishek  Dixit46, Emma 
 Donoghue22, Jens  Dreier47, Guy-Loup Dulière48, Ari  Ercole46, Patrick  Esser41, 
Erzsébet  Ezer49, Martin  Fabricius50, Valery L.  Feigin51, Kelly  Foks52, Shirin 
 Frisvold53, Alex  Furmanov54, Pablo  Gagliardo55, Damien  Galanaud16, Dashiell 
 Gantner28, Guoyi  Gao56, Pradeep  George57, Alexandre  Ghuysen58, Lelde  Giga59, 
Ben  Glocker60, Jagoš  Golubovic45, Pedro A. Gomez 61, Johannes  Gratz62, 
Benjamin  Gravesteijn33, Francesca  Grossi43, Russell L.  Gruen63, Deepak  Gupta64, 
Juanita A.  Haagsma33, Iain  Haitsma65, Raimund  Helbok13, Eirik  Helseth66, 
Lindsay Horton 67, Jilske  Huijben33, Peter J.  Hutchinson68, Bram  Jacobs69, Stefan 
 Jankowski70, Mike  Jarrett21, Ji-yao  Jiang56, Kelly  Jones51, Mladen  Karan47, 
Angelos G.  Kolias68, Erwin  Kompanje71, Daniel  Kondziella50, Evgenios 
 Koraropoulos46, Lars-Owe  Koskinen72, Noémi Kovács73, Alfonso  Lagares61, 
Linda  Lanyon57, Steven  Laureys74, Fiona  Lecky75, Rolf  Lefering76, Valerie 
 Legrand77, Aurelie  Lejeune78, Leon  Levi79, Roger  Lightfoot80, Hester  Lingsma33, 
Andrew I.R.  Maas42, Ana M. Castaño-León61, Marc  Maegele81, Marek  Majdan20, 
Alex  Manara82, Geoffrey  Manley83, Costanza  Martino84, Hugues Maréchal48, 
Julia  Mattern85, Catherine  McMahon86, Béla  Melegh87, David  Menon46, Tomas 
 Menovsky42, Davide  Mulazzi27, Visakh  Muraleedharan57, Lynnette  Murray28, 
Nandesh  Nair42, Ancuta  Negru88, David  Nelson1, Virginia  Newcombe46, Daan 
 Nieboer33, Quentin  Noirhomme74, József Nyirádi2, Otesile  Olubukola75, Matej 
Page 9 of 11Sewalt et al. Scand J Trauma Resusc Emerg Med          (2021) 29:113  
 Oresic89, Fabrizio  Ortolano27, Aarno  Palotie90, 91, 92, Paul M.  Parizel93, Jean-Fran-
çois  Payen94, Natascha  Perera12, Vincent  Perlbarg16, Paolo  Persona95, Wilco 
 Peul96, Anna Piippo-Karjalainen97, Matti  Pirinen90, Horia  Ples88, Suzanne 
 Polinder33, Inigo  Pomposo29, Jussi P. Posti 98, Louis  Puybasset99, Andreea Radoi 
100, Arminas  Ragauskas101, Rahul  Raj97, Malinka  Rambadagalla102, Ruben  Real38, 
Jonathan  Rhodes103, Sylvia  Richardson104, Sophie  Richter46, Samuli  Ripatti90, 
Saulius  Rocka101, Cecilie  Roe105, Olav  Roise106,140, Jonathan  Rosand107, Jeffrey V. 
 Rosenfeld108, Christina  Rosenlund109, Guy  Rosenthal54, Rolf  Rossaint34, Sandra 
 Rossi95, Daniel  Rueckert60, Martin Rusnák110, Juan  Sahuquillo100, Oliver 
 Sakowitz85, 111, Renan Sanchez-Porras111, Janos  Sandor112, Nadine Schäfer76, 
Silke  Schmidt113, Herbert  Schoechl114, Guus  Schoonman115, Rico Frederik 
 Schou116, Elisabeth  Schwendenwein6, Charlie  Sewalt33, Toril  Skandsen117, 118, 
Peter  Smielewski26, Abayomi  Sorinola119, Emmanuel  Stamatakis46, Simon 
 Stanworth39, Ana  Kowark34, Robert  Stevens120, William  Stewart121, Ewout W. 
 Steyerberg33, 122, Nino  Stocchetti123, Nina Sundström124, Anneliese  Synnot22, 
125, Riikka  Takala126, Viktória Tamás119, Tomas  Tamosuitis127, Mark Steven 
 Taylor20, Braden Te  Ao51, Olli  Tenovuo98, Alice  Theadom51, Matt  Thomas82, Dick 
 Tibboel128, Marjolein  Timmers71, Christos  Tolias129, Tony  Trapani28, Cristina 
Maria  Tudora88, Peter Vajkoczy 130, Shirley  Vallance28, Egils  Valeinis59, Zoltán 
Vámos49, Gregory Van der  Steen42, Joukje van der  Naalt69, Jeroen T.J.M. van 
Dijck 96, Thomas A. van  Essen96, Wim Van  Hecke131, Caroline van  Heugten132, 
Dominique Van  Praag133, Thijs Vande  Vyvere131, Audrey  Vanhaudenhuyse16, 74, 
Roel P. J. van  Wijk97, Alessia  Vargiolu32,  EmmanuelVega79, Kimberley  Velt33, Jan 
 Verheyden131, Paul M.  Vespa134, Anne  Vik117, 135, Rimantas  Vilcinis127, Victor 
 Volovici65, Nicole von Steinbüchel38, Daphne  Voormolen33, Petar  Vulekovic45, 
Kevin K.W.  Wang136, Eveline  Wiegers33, Guy  Williams46, Lindsay  Wilson67, Stefan 
 Winzeck46, Stefan  Wolf137, Zhihui  Yang136, Peter Ylén138, Alexander  Younsi85, 
Frederik A.  Zeiler46,139, Veronika  Zelinkova20, Agate  Ziverte59, Tommaso 
 Zoerle27. 1Department of Physiology and Pharmacology, Section of 
Perioperative Medicine and Intensive Care, Karolinska Institutet, Stockholm, 
Sweden. 2János Szentágothai Research Centre, University of Pécs, Pécs, 
Hungary . 3Division of Surgery and Clinical Neuroscience, Department of 
Physical Medicine and Rehabilitation, Oslo University Hospital and University 
of Oslo, Oslo, Norway. 4Department of Neurosurgery, University Hospital 
Northern Norway, Tromso, Norway. 5Department of Physical Medicine and 
Rehabilitation, University Hospital Northern Norway, Tromso, Norway. 6Trauma 
Surgery, Medical University Vienna, Vienna, Austria. 7Department of 
Anesthesiology & Intensive Care, University Hospital Nancy, Nancy, France. 
8Raymond Poincare hospital, Assistance Publique – Hopitaux de Paris, Paris, 
France. 9Department of Anesthesiology & Intensive Care, S Raffaele University 
Hospital, Milan, Italy. 10Department of Neurosurgery, Radboud University 
Medical Center, Nijmegen, The Netherlands. 11Department of Neurosurgery, 
University of Szeged, Szeged, Hungary. 12International Projects Management, 
ARTTIC, Munchen, Germany. 13Department of Neurology, Neurological 
Intensive Care Unit, Medical University of Innsbruck, Innsbruck, Austria. 
14Department of Neurosurgery & Anesthesia & intensive care medicine, 
Karolinska University Hospital, Stockholm, Sweden. 15NIHR Surgical 
Reconstruction and Microbiology Research Centre, Birmingham, UK. 
16Anesthesie-Réanimation, Assistance Publique – Hopitaux de Paris, Paris, 
France. 17Department of Anesthesia & ICU, AOU Città della Salute e della 
Scienza di Torino—Orthopedic and Trauma Center, Torino, Italy. 18Department 
of Neurology, Odense University Hospital, Odense, Denmark . 19Behaviour-
Works Australia, Monash Sustainability Institute, Monash University, Victoria, 
Australia. 20Department of Public Health, Faculty of Health Sciences and Social 
Work, Trnava University, Trnava, Slovakia. 21Quesgen Systems Inc., Burlingame, 
California, USA. 22Australian & New Zealand Intensive Care Research Centre, 
Department of Epidemiology and Preventive Medicine, School of Public 
Health and Preventive Medicine, Monash University, Melbourne, Australia. 
23Department of Surgery and Perioperative Science, Umeå University, Umeå, 
Sweden. 24Department of Neurosurgery, Medical School, University of Pécs, 
Hungary and Neurotrauma Research Group, János Szentágothai Research 
Centre, University of Pécs, Hungary. 25Department of Medical Psychology, 
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. 26Brain Physics 
Lab, Division of Neurosurgery, Dept of Clinical Neurosciences, University of 
Cambridge, Addenbrooke’s Hospital, Cambridge, UK. 27Neuro ICU, Fondazione 
IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy. 28ANZIC Research 
Centre, Monash University, Department of Epidemiology and Preventive 
Medicine, Melbourne, Victoria, Australia. 29Department of Neurosurgery, 
Hospital of Cruces, Bilbao, Spain. 30NeuroIntensive Care, Niguarda Hospital, 
Milan, Italy. 31School of Medicine and Surgery, Università Milano Bicocca, 
Milano, Italy. 32NeuroIntensive Care, ASST di Monza, Monza, Italy. 
33Department of Public Health, Erasmus Medical Center-University Medical 
Center, Rotterdam, The Netherlands. 34Department of Anaesthesiology, 
University Hospital of Aachen, Aachen, Germany. 35Department of Anesthesia 
& Neurointensive Care, Cambridge University Hospital NHS Foundation Trust, 
Cambridge, UK. 36School of Public Health & PM, Monash University and The 
Alfred Hospital, Melbourne, Victoria, Australia. 37Radiology/MRI department, 
MRC Cognition and Brain Sciences Unit, Cambridge, UK. 38Institute of Medical 
Psychology and Medical Sociology, Universitätsmedizin Göttingen, Göttingen, 
Germany. 39Oxford University Hospitals NHS Trust, Oxford, UK . 40Intensive Care 
Unit, CHU Poitiers, Potiers, France. 41Movement Science Group, Faculty of 
Health and Life Sciences, Oxford Brookes University, Oxford, UK. 42Department 
of Neurosurgery, Antwerp University Hospital and University of Antwerp, 
Edegem, Belgium. 43Department of Anesthesia & Intensive Care, Maggiore 
Della Carità Hospital, Novara, Italy. 44Department of Neurosurgery, University 
Hospitals Leuven, Leuven, Belgium. 45Department of Neurosurgery, Clinical 
centre of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, 
Serbia. 46Division of Anaesthesia, University of Cambridge, Addenbrooke’s 
Hospital, Cambridge, UK. 47Center for Stroke Research Berlin, Charité 
– Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, 
Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. 
48Intensive Care Unit, CHR Citadelle, Liège, Belgium. 49Department of 
Anaesthesiology and Intensive Therapy, University of Pécs, Pécs, Hungary. 
50Departments of Neurology, Clinical Neurophysiology and Neuroanesthesiol-
ogy, Region Hovedstaden Rigshospitalet, Copenhagen, Denmark. 51National 
Institute for Stroke and Applied Neurosciences, Faculty of Health and 
Environmental Studies, Auckland University of Technology, Auckland, New 
Zealand. 52Department of Neurology, Erasmus MC, Rotterdam, the Nether-
lands. 53Department of Anesthesiology and Intensive care, University Hospital 
Northern Norway, Tromso, Norway. 54Department of Neurosurgery, 
Hadassah-hebrew University Medical center, Jerusalem, Israel. 55Fundación 
Instituto Valenciano de Neurorrehabilitación (FIVAN), Valencia, Spain. 
56Department of Neurosurgery, Shanghai Renji hospital, Shanghai Jiaotong 
University/school of medicine, Shanghai, China. 57Karolinska Institutet, INCF 
International Neuroinformatics Coordinating Facility, Stockholm, Sweden. 
58Emergency Department, CHU, Liège, Belgium. 59Neurosurgery clinic, Pauls 
Stradins Clinical University Hospital, Riga, Latvia. 60Department of Computing, 
Imperial College London, London, UK. 61Department of Neurosurgery, Hospital 
Universitario 12 de Octubre, Madrid, Spain. 62Department of Anesthesia, 
Critical Care and Pain Medicine, Medical University of Vienna, Austria. 63College 
of Health and Medicine, Australian National University, Canberra, Australia. 
64Department of Neurosurgery, Neurosciences Centre & JPN Apex trauma 
centre, All India Institute of Medical Sciences, New Delhi-110029, India. 
65Department of Neurosurgery, Erasmus MC, Rotterdam, the Netherlands. 
66Department of Neurosurgery, Oslo University Hospital, Oslo, Norway. 
67Division of Psychology, University of Stirling, Stirling, UK. 68Division of 
Neurosurgery, Department of Clinical Neurosciences, Addenbrooke’s Hospital 
& University of Cambridge, Cambridge, UK. 69Department of Neurology, 
University of Groningen, University Medical Center Groningen, Groningen, 
Netherlands. 70Neurointensive Care , Sheffield Teaching Hospitals NHS 
Foundation Trust, Sheffield, UK. 71Department of Intensive Care and 
Department of Ethics and Philosophy of Medicine, Erasmus Medical Center, 
Rotterdam, The Netherlands. 72Department of Clinical Neuroscience, 
Neurosurgery, Umeå University, Umeå, Sweden. 73Hungarian Brain Research 
Program—Grant No. KTIA_13_NAP-A-II/8, University of Pécs, Pécs, Hungary. 
74Cyclotron Research Center , Universityof Liège, Liège, Belgium. 75Emergency 
Medicine Research in Sheffield, Health Services Research Section, School of 
Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK. 
76Institute of Research in Operative Medicine (IFOM), Witten/Herdecke 
University, Cologne, Germany. 77VP Global Project Management CNS, ICON, 
Paris, France. 78Department of Anesthesiology-Intensive Care, Lille University 
Hospital, Lille, France. 79Department of Neurosurgery, Rambam Medical 
Center, Haifa, Israel. 80Department of Anesthesiology & Intensive Care, 
University Hospitals Southhampton NHS Trust, Southhampton, UK. 
81Cologne-Merheim Medical Center (CMMC), Department of Traumatology, 
Orthopedic Surgery and Sportmedicine, Witten/Herdecke University, Cologne, 
Germany. 82Intensive Care Unit, Southmead Hospital, Bristol, Bristol, UK. 
83Department of Neurological Surgery, University of California, San Francisco, 
California, USA. 84Department of Anesthesia & Intensive Care, M. Bufalini 
Hospital, Cesena, Italy. 85Department of Neurosurgery, University Hospital 
Heidelberg, Heidelberg, Germany. 86Department of Neurosurgery, The Walton 
centre NHS Foundation Trust, Liverpool, UK. 87Department of Medical 
Page 10 of 11Sewalt et al. Scand J Trauma Resusc Emerg Med          (2021) 29:113 
Genetics, University of Pécs, Pécs, Hungary . 88Department of Neurosurgery, 
Emergency County Hospital Timisoara, Timisoara, Romania. 89School of 
Medical Sciences, Örebro University, Örebro, Sweden. 90Institute for Molecular 
Medicine Finland, University of Helsinki, Helsinki, Finland. 91Analytic and 
Translational Genetics Unit, Department of Medicine; Psychiatric & Neurode-
velopmental Genetics Unit, Department of Psychiatry; Department of 
Neurology, Massachusetts General Hospital, Boston, MA, USA. 92Program in 
Medical and Population Genetics; The Stanley Center for Psychiatric Research, 
The Broad Institute of MIT and Harvard, Cambridge, MA, USA. 93Department of 
Radiology, Antwerp University Hospital and University of Antwerp, Edegem, 
Belgium. 94Department of Anesthesiology & Intensive Care, University Hospital 
of Grenoble, Grenoble, France. 95Department of Anesthesia & Intensive Care, 
Azienda Ospedaliera Università di Padova, Padova, Italy. 96Dept. of Neurosur-
gery, Leiden University Medical Center, Leiden, The Netherlands and Dept. of 
Neurosurgery, Medical Center Haaglanden, The Hague, The Netherlands. 
97Department of Neurosurgery, Helsinki University Central Hospital. 98Division 
of Clinical Neurosciences, Department of Neurosurgery and Turku Brain Injury 
Centre, Turku University Hospital and University of Turku, Turku, Finland. 
99Department of Anesthesiology and Critical Care, Pitié -Salpêtrière Teaching 
Hospital, Assistance Publique, Hôpitaux de Paris and University Pierre et Marie 
Curie, Paris, France. 100Neurotraumatology and Neurosurgery Research Unit 
(UNINN), Vall d’Hebron Research Institute, Barcelona, Spain. 101Department of 
Neurosurgery, Kaunas University of technology and Vilnius University, Vilnius, 
Lithuania. 102Department of Neurosurgery, Rezekne Hospital, Latvia. 
103Department of Anaesthesia, Critical Care & Pain Medicine NHS Lothian & 
University of Edinburg, Edinburgh, UK. 104Director, MRC Biostatistics Unit, 
Cambridge Institute of Public Health, Cambridge, UK. 105Department of 
Physical Medicine and Rehabilitation, Oslo University Hospital/University of 
Oslo, Oslo, Norway. 106Division of Orthopedics, Oslo University Hospital . 
107Broad Institute, Cambridge MA Harvard Medical School, Boston MA, 
Massachusetts General Hospital, Boston MA, USA. 108National Trauma Research 
Institute, The Alfred Hospital, Monash University, Melbourne, Victoria, Australia. 
109Department of Neurosurgery, Odense University Hospital, Odense, 
Denmark. 110International Neurotrauma Research Organisation, Vienna, 
Austria. 111Klinik für Neurochirurgie, Klinikum Ludwigsburg, Ludwigsburg, 
Germany. 112Division of Biostatistics and Epidemiology, Department of 
Preventive Medicine, University of Debrecen, Debrecen, Hungary. 113Depart-
ment Health and Prevention, University Greifswald, Greifswald, Germany. 
114Department of Anaesthesiology and Intensive Care, AUVA Trauma Hospital, 
Salzburg, Austria. 115Department of Neurology, Elisabeth-TweeSteden 
Ziekenhuis, Tilburg, the Netherlands. 116Department of Neuroanesthesia and 
Neurointensive Care, Odense University Hospital, Odense, Denmark. 
117Department of Neuromedicine and Movement Science, Norwegian 
University of Science and Technology, NTNU, Trondheim, Norway. 118Depart-
ment of Physical Medicine and Rehabilitation, St.Olavs Hospital, Trondheim 
University Hospital, Trondheim, Norway. 119Department of Neurosurgery, 
University of Pécs, Pécs, Hungary . 120Division of Neuroscience Critical Care, 
John Hopkins University School of Medicine, Baltimore, USA. 121Department of 
Neuropathology, Queen Elizabeth University Hospital and University of 
Glasgow, Glasgow, UK. 122Dept. of Department of Biomedical Data Sciences, 
Leiden University Medical Center, Leiden, The Netherlands . 123Department of 
Pathophysiology and Transplantation, Milan University, and Neuroscience ICU, 
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy. 
124Department of Radiation Sciences, Biomedical Engineering, Umeå 
University, Umeå, Sweden. 125Cochrane Consumers and Communication 
Review Group, Centre for Health Communication and Participation, School of 
Psychology and Public Health, La Trobe University, Melbourne, Australia. 
126Perioperative Services, Intensive Care Medicine and Pain Management, 
Turku University Hospital and University of Turku, Turku, Finland. 127Depart-
ment of Neurosurgery, Kaunas University of Health Sciences, Kaunas, 
Lithuania. 128Intensive Care and Department of Pediatric Surgery, Erasmus 
Medical Center, Sophia Children’s Hospital, Rotterdam, The Netherlands. 
129Department of Neurosurgery, Kings college London, London, UK. 
130Neurologie, Neurochirurgie und Psychiatrie, Charité – Universitätsmedizin 
Berlin, Berlin, Germany. 131icoMetrix NV, Leuven, Belgium. 132Movement 
Science Group, Faculty of Health and Life Sciences, Oxford Brookes University, 
Oxford, UK. 133Psychology Department, Antwerp University Hospital, Edegem, 
Belgium. 134Director of Neurocritical Care, University of California, Los Angeles, 
USA. 135Department of Neurosurgery, St.Olavs Hospital, Trondheim University 
Hospital, Trondheim, Norway. 136Department of Emergency Medicine, 
University of Florida, Gainesville, Florida, USA. 137Department of Neurosurgery, 
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität 
Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, 
Germany. 138VTT Technical Research Centre, Tampere, Finland. 139Section of 
Neurosurgery, Department of Surgery, Rady Faculty of Health Sciences, 
University of Manitoba, Winnipeg, MB, Canada. 140Institute of Clinical Medicine, 
Faculty of Medicine, University of Oslo.
Authors’ contributions
CAS, BYG, EV and HL analyzed and interpreted the patient data. FL, AM, NS, 
DM and HL were major contributors in writing the manuscript. All authors 
read and approved the final manuscript.
Funding
CENTER-TBI was supported by the European Union 7th Framework program 
(EC Grant 602150). Additional funding was obtained from the Hannelore 
Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences 
Corporation (USA).
Availability of data and materials
The data that support the findings of this study are available from https:// 
www. center- tbi. eu but restrictions apply to the availability of these data, 
which were used under license for the current study, and so are not publicly 
available. Data are however available from the authors upon reasonable 
request and with permission of CENTER-TBI.
Declarations
Ethics approval and consent to participate
Ethical approval was obtained for each recruiting site. Consent was obtained 
for all patients enrolled in the Core study. The list of sites, Ethical Committees, 
approval numbers and approval dates can be found on the website: https:// 




The authors declare that they have no competing interests.
Author details
1 Department of Public Health, Erasmus MC Medical Center, Postbus 2040, 
3000 CA Rotterdam, The Netherlands. 2 Department of Anesthesiology, 
Erasmus MC Medical Center, Rotterdam, The Netherlands. 3 Division of Anaes-
thesia, Addenbrooke’s Hospital, University of Cambridge, Cambridge, UK. 
4 Department of Neurosurgery, Antwerp University Hospital, and University 
of Antwerp, Edegem, Belgium. 5 Department of Pathophysiology and Trans-
plantation, Milan University, and Neuroscience ICU, Fondazione IRCCS Cà 
Granda Ospedale Maggiore Policlinico, Milan, Italy. 6 Department of Neurology, 
Erasmus MC Medical Center, Rotterdam, The Netherlands. 7 Center for Urgent 
and Emergency Care Research (CURE), Health Services Research Section, 
School of Health and Related Research (ScHARR), University of Sheffield, Shef-
field, UK. 
Received: 5 January 2021   Accepted: 27 July 2021
References
 1. Maas AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, et al. 
Traumatic brain injury: integrated approaches to improve prevention, 
clinical care, and research. Lancet Neurol. 2017;16(12):987–1048.
 2. Roozenbeek B, Maas AIR, Menon DK. Changing patterns in the epide-
miology of traumatic brain injury. Nat Rev Neurol. 2013;9(4):231–6.
 3. Collaborators GBDN. Global, regional, and national burden of neu-
rological disorders, 1990–2016: a systematic analysis for the Global 
Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–80.
 4. McConnell KJ, Newgard CD, Mullins RJ, Arthur M, Hedges JR. Mortality 
benefit of transfer to level I versus level II trauma centers for head-injured 
patients. Health Serv Res. 2005;40(2):435–57.
Page 11 of 11Sewalt et al. Scand J Trauma Resusc Emerg Med          (2021) 29:113  
 5. Mendeloff JM, Cayten CG. Trauma systems and public policy. Annu Rev 
Public Health. 1991;12:401–24.
 6. DuBose JJ, Browder T, Inaba K, Teixeira PG, Chan LS, Demetriades D. Effect of 
trauma center designation on outcome in patients with severe traumatic 
brain injury. Arch Surg. 2008;143(12):1213–7 (discussion 7).
 7. Mirski MA, Chang CW, Cowan R. Impact of a neuroscience intensive care 
unit on neurosurgical patient outcomes and cost of care: evidence-based 
support for an intensivist-directed specialty ICU model of care. J Neurosurg 
Anesthesiol. 2001;13(2):83–92.
 8. Hartl R, Gerber LM, Iacono L, Ni QH, Lyons K, Ghajar J. Direct transport within 
an organized state trauma system reduces mortality in patients with severe 
traumatic brain injury. J Trauma-Injury Infect Crit Care. 2006;60(6):1250–6.
 9. Bernard SA, Nguyen V, Cameron P, Masci K, Fitzgerald M, Cooper DJ, et al. 
Prehospital rapid sequence intubation improves functional outcome for 
patients with severe traumatic brain injury: a randomized controlled trial. 
Ann Surg. 2010;252(6):959–65.
 10. Cnossen MC, van der Brande R, Lingsma HF, Polinder S, Lecky F, Maas 
AIR. Prehospital Trauma Care among 68 European Neurotrauma Centers: 
Results of the CENTER-TBI Provider Profiling Questionnaires. J Neurotrauma. 
2018;36(1):176–81.
 11. Helling TS, Davit F, Edwards K. First Echelon Hospital Care before Trauma 
Center transfer in a rural trauma system: does it affect outcome? J Trauma-
Injury Infect Crit Care. 2010;69(6):1362–6.
 12. Pickering A, Cooper K, Harnan S, Sutton A, Mason S, Nicholl J. Impact of 
prehospital transfer strategies in major trauma and head injury: systematic 
review, meta-analysis, and recommendations for study design. J Trauma 
Acute Care Surg. 2015;78(1):164–77.
 13. Lecky FE, Russell W, McClelland G, Pennington E, Fuller G, Goodacre S, 
et al. Bypassing nearest hospital for more distant neuroscience care in 
head-injured adults with suspected traumatic brain injury: findings of the 
head injury transportation straight to neurosurgery (HITS-NS) pilot cluster 
randomised trial. BMJ Open. 2017;7(10):e016355.
 14. Hoogmartens O, Heselmans A, Van de Velde S, Castren M, Sjolin H, Sabbe M, 
et al. Evidence-based prehospital management of severe traumatic brain 
injury: a comparative analysis of current clinical practice guidelines. Prehosp 
Emerg Care. 2014;18(2):265–73.
 15. Badjatia N, Carney N, Crocco TJ, Fallat ME, Hennes HM, Jagoda AS, et al. 
Guidelines for prehospital management of traumatic brain injury 2nd edi-
tion. Prehosp Emerg Care. 2008;12(Suppl 1):1–52.
 16. Gabriel EJ, Ghajar J, Jagoda A, Pons PT, Scalea T, Walters BC, et al. Guidelines 
for prehospital management of traumatic brain injury. J Neurotrauma. 
2002;19(1):111–74.
 17. Maas AIR, Menon DK, Steyerberg EW, Citerio G, Lecky F, Manley GT, et al. 
Collaborative European NeuroTrauma Effectiveness Research in Traumatic 
Brain Injury (CENTER-TBI): a prospective longitudinal observational study. 
Neurosurgery. 2015;76(1):67–80.
 18. Cnossen MC, Polinder S, Lingsma HF, Maas AIR, Menon D, Steyerberg EW, 
et al. Variation in structure and process of care in traumatic brain injury: 
provider profiles of European Neurotrauma Centers participating in the 
CENTER-TBI Study. PLoS ONE. 2016;11(8):e0161367.
 19. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A 
practical scale. Lancet. 1974;2(7872):81–4.
 20. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, 
et al. Strengthening the Reporting of Observational Studies in Epidemiol-
ogy (STROBE) statement: guidelines for reporting observational studies. 
BMJ. 2007;335(7624):806–8.
 21. Steyerberg EW, Wiegers E, Sewalt C, Buki A, Citerio G, De Keyser V, et al. Case-
mix, care pathways, and outcomes in patients with traumatic brain injury in 
CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study. 
Lancet Neurol. 2019;18(10):923–34.
 22. Kunzmann K, Wernisch L, Richardson S, Steyerberg E, Lingsma H, A E. Impu-
tation of ordinal outcomes: a comparison of approaches in traumatic brain 
injury. J Neurotrauma. 2019;38(4):455–63.
 23. Dijkland SA, Foks KA, Polinder S, Dippel DWJ, Maas AIR, Lingsma HF, et al. 
Prognosis in moderate and severe traumatic brain injury: a systematic 
review of contemporary models and validation studies. J Neurotrauma. 
2019;37(1):1–13.
 24. Gravesteijn BY, Sewalt CA, Venema E, Nieboer D, Steyerberg EW. Missing 
data in prediction research: a five-step approach for multiple imputation, 
illustrated in the CENTER-TBI Study. J Neurotrauma. 2021;38(13):1842–57.
 25. Merlo J, Chaix B, Yang M, Lynch J, Rastam L. A brief conceptual tutorial of 
multilevel analysis in social epidemiology: linking the statistical concept of 
clustering to the idea of contextual phenomenon. J Epidemiol Community 
Health. 2005;59(6):443–9.
 26. Citerio G, Stocchetti N, Cormio M, Beretta L, Galli D, Pesenti A. Application 
of guidelines for severe head trauma: data from an Italian database. Eur J 
Emerg Med. 2003;10(1):68–72.
 27. Patel HC, Bouamra O, Woodford M, King AT, Yates DW, Lecky FE, et al. Trends 
in head injury outcome from 1989 to 2003 and the effect of neurosurgical 
care: an observational study. Lancet. 2005;366(9496):1538–44.
 28. Stranjalis G, Bouras T, Korfias S, Andrianakis I, Pitaridis M, Tsamandouraki K, 
et al. Outcome in 1,000 head injury hospital admissions: the Athens head 
trauma registry. J Trauma. 2008;65(4):789–93.
 29. Joosse P, Saltzherr TP, van Lieshout WA, van Exter P, Ponsen KJ, Vandertop WP, 
et al. Impact of secondary transfer on patients with severe traumatic brain 
injury. J Trauma Acute Care Surg. 2012;72(2):487–90.
 30. Tepas JJ 3rd, Pracht EE, Orban BL, Flint LM. High-volume trauma centers 
have better outcomes treating traumatic brain injury. J Trauma Acute Care 
Surg. 2013;74(1):143–7 (discussion 7–8).
 31. Haselsberger K, Pucher R, Auer LM. Prognosis after acute subdural or epi-
dural haemorrhage. Acta Neurochir (Wien). 1988;90(3–4):111–6.
 32. Fuller G, Bouamra O, Woodford M, Jenks T, Patel H, Coats TJ, et al. The effect 
of specialist neurosciences care on outcome in adult severe head injury: a 
cohort study. J Neurosurg Anesthesiol. 2011;23(3):198–205.
 33. Elf K, Nilsson P, Enblad P. Outcome after traumatic brain injury improved by 
an organized secondary insult program and standardized neurointensive 
care. Crit Care Med. 2002;30(9):2129–34.
 34. Walcott BP, Khanna A, Kwon CS, Phillips HW, Nahed BV, Coumans JV. Time 
interval to surgery and outcomes following the surgical treatment of acute 
traumatic subdural hematoma. J Clin Neurosci. 2014;21(12):2107–11.
 35. Gravesteijn BY, Sewalt CA, Stocchetti N, Citerio G, Ercole A, Lingsma HF, et al. 
Prehospital management of traumatic brain injury across Europe: a CENTER-
TBI study. Prehosp Emerg Care. 2020. 1–15.
 36. Spaite DW, Hu C, Bobrow BJ, Chikani V, Sherrill D, Barnhart B, et al. Mortal-
ity and prehospital blood pressure in patients with major traumatic 
brain injury: implications for the hypotension threshold. JAMA Surg. 
2017;152(4):360–8.
 37. Gomes E, Araujo R, Carneiro A, Dias C, Costa-Pereira A, Lecky FE. The 
importance of pre-trauma centre treatment of life-threatening events on 
the mortality of patients transferred with severe trauma. Resuscitation. 
2010;81(4):440–5.
 38. Harrison DA, Prabhu G, Grieve R, Harvey SE, Sadique MZ, Gomes M, et al. 
Risk Adjustment In Neurocritical care (RAIN)-prospective validation of risk 
prediction models for adult patients with acute traumatic brain injury to use 
to evaluate the optimum location and comparative costs of neurocritical 
care: a cohort study. Health Technol Assess. 2013;17(23):vii–viii, 1–350.
 39. Griffith DA, Bennett RJ, Haining RP. Statistical analysis of spatial data in the 
presence of missing observations: a methodological guide and an applica-
tion to urban census data. Environ Plan A. 1989;21(11):1, 511–23.
 40. Fabbri A, Servadei F, Marchesini G, Stein SC, Vandelli A. Observational 
approach to subjects with mild-to-moderate head injury and initial non-
neurosurgical lesions. J Neurol Neurosurg Psychiatry. 2008;79(10):1180–5.
 41. Lecky F, Russell W, Fuller G, McClelland G, Pennington E, Goodacre S, et al. 
The Head Injury Transportation Straight to Neurosurgery (HITS-NS) ran-
domised trial: a feasibility study. Health Technol Assess. 2016;20(1):1–198.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
